Researchers at the Medical College of Wisconsin in Milwaukee, in collaboration with a national team, have developed a biodefense cocktail which activates the immune system against a broad range of viruses and bacteria. The new treatment boosts the bodys response against common characteristics of germs. It is expected to be deployed to U.S. troops within the next five years. Using a nasal spray, the cocktail of drugs will trigger immune activation in the respiratory and gastrointestinal tracts, the most likely routes of attack.
The study was published in the December 2005 issue of Journal of Allergy & Clinical Immunology. Catherine Amlie-Lefond, MD, assistant professor of neurology, is the first author, and Harry T. Whelan, MD, professor of neurology, is the senior author.
According to Whelan, This will revolutionize our defense against germ warfare, as well as the treatment of infectious diseases in our population, as a whole. It is possible to include agents which inhibit molecular events leading to septic shock, as well. This new technology confers broad spectrum, short term, immunity against unknown biothreat agents for war fighters sent into harm's way.
Whelan, who is a captain in the Navy, holds the Bleser Endowed Professorship through the Childrens Hospital of Wisconsin Foundation.
Source: Medical College of Wisconsin
Â
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.